bye bye traders. I might be stupid but for this MC the potential is HUGE as I see it and progress is clearly being made. Analytics revenue is going to grow strongly over coming quarters, working capital to see us at least through the promarker commercialisation, great partnerships with pharmaceutical coys leading to possible licenses and potential new biomarker discoveries initially in lung conditions and who knows what else will be a rinse and repeat proposition. I don't think the market gets PIQs disruptive biomarker discovery technology.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - December 2017 Quarterly Report
PIQ
proteomics international laboratories ltd
Add to My Watchlist
3.45%
!
30.0¢

bye bye traders. I might be stupid but for this MC the potential...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $49.05M |
Open | High | Low | Value | Volume |
30.5¢ | 30.5¢ | 29.0¢ | $48.86K | 162.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8700 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.300 |
3 | 56779 | 0.295 |
4 | 23542 | 0.290 |
1 | 10000 | 0.285 |
4 | 40643 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 5000 | 1 |
0.310 | 1712 | 2 |
0.315 | 712 | 1 |
0.330 | 30149 | 2 |
0.345 | 1260 | 1 |
Last trade - 10.42am 27/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online